NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
1.260
-0.030 (-2.33%)
At close: Oct 16, 2026, 4:00 PM EDT
1.280
+0.020 (1.59%)
After-hours: Oct 16, 2026, 4:29 PM EDT
NovaBridge Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
30
Market Cap
146.16M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 632.00K | 2.18M | - |
| Dec 31, 2022 | -1.55M | -15.40M | - |
| Dec 31, 2021 | 13.85M | -222.30M | -94.14% |
| Dec 31, 2020 | 236.15M | 231.84M | 5,381.18% |
| Dec 31, 2019 | 4.31M | -3.51M | -44.90% |
| Dec 31, 2018 | 7.82M | 6.04M | 340.20% |
| Dec 31, 2017 | 1.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Codexis | 77.68M |
| MediWound | 11.86M |
| Adagene | 9.29M |
| Molecular Partners AG | 856.30K |
| Compass Therapeutics | 850.00K |
| Veraxa Biotech AG | 29.54K |
NBP News
- 3 days ago - Wuhan Hiteck enters exclusive license agreement with Visara - TheFly
- 3 days ago - Hiteck Licenses Investigational Next-Generation NGF Eye Drop HT006.2.2 to Visara for Neurotrophic Keratitis Outside Greater China - PRNewsWire
- 3 days ago - Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis - GlobeNewsWire
- 8 days ago - NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026 - GlobeNewsWire
- 4 weeks ago - NovaBridge Biosciences Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 5 weeks ago - NovaBridge Biosciences Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 5 weeks ago - NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director - GlobeNewsWire
- 7 weeks ago - NovaBridge Biosciences to Participate in September Investor Conferences - GlobeNewsWire